Glypican 3

Glypican 3

Glypican 3 분자 정보

Molecule Name
Glypican-3
분자 별명
GPC3,OCI5,Glypican-3,GTR2-2,MXR7,DGSX,SDYS ,SGB,SGBS,SGBS1
Drug Development Progress
임상 약물 수58
시판 약물 수0
최고 연구 개발 단계Phase 2 Clinical
표적 별명
MXR7,OCI5,GPC3,Glypican-3,Glypican 3,Glypican Proteoglycan 3,GTR2-2,Secreted Glypican-3,OCI-5,SGBS1,DGSX,SGBS,SDYS,SGB,Intestinal protein OCI-5,Heparan Sulphate Proteoglycan
분자 배경
Glypican-3 (GPC3) is also known as Intestinal protein OCI-5, GTR2-2, MXR7, which belongs to the glypican family. Glypican 3 / GPC-3 is highly expressed in lung, liver and kidney. Glypican-3 inhibits the dipeptidyl peptidase activity of DPP4. Glypican-3 may be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs, and also may play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function.

Glypican 3 제품 목록

Species
  • Human(17)
  • Cynomolgus(3)
  • Mouse(3)
  • Rat(1)
Tag
  • His Tag(16)
  • Fc Tag(5)
  • Llama IgG Fc Tag(2)
  • His Tag & Avi Tag(1)
Host
  • HEK293(24)
Conjugate
  • Unconjugated(15)
  • APC Labeled(3)
  • FITC Labeled(2)
  • PE Labeled(2)
  • AF488 Labeled(1)
  • Biotin-labeled(1)
Grade
  • RUO(21)
  • PG (pre-GMP)(3)
Low Endotoxin
  • Yes(6)
  • No(18)
You Have Viewed 1-10 Of 24 Results
  • 1
  • 2
  • 3

Can’t find what you need?

Submit your requirements and our technical
team will help.

FAQ

Can I obtain fluorescently labeled GPC3 reagents?

Selected GPC3 products are labeled with FITC, PE, APC or Alexa Fluor 488. Match the label to the assay platform and panel design.

What are the applications of recombinant GPC3 protein?

Recombinant GPC3 proteins can support antibody development, CAR-T cell research, ligand-binding assays, and other studies of GPC3-targeted therapeutics.

What tag options can I select for recombinant GPC3?

His, Fc, His/Avi and llama-IgG-Fc formats are listed, along with tag-free products. The tag should fit the planned immobilization and detection strategy.

Which species are represented in the GPC3 protein range?

Human, cynomolgus, mouse and rat products are listed. Choose the species that matches the binder and model used in the study.

What GPC3 reagent types are available for assay development?

The collection includes recombinant GPC3 proteins, GPC3-expressing cells and GPC3-coupled magnetic beads.
Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
GPC-3298306GPC-3298306Phase 2 ClinicalNational Cancer Center Of Japan
Carcinoma, Hepatocellular; Ovarian Neoplasms
상세
BOS-342PRS-342; BOS-342; PRS-342/BOS-342Phase 2 ClinicalPieris Pharmaceuticals
Carcinoma, Hepatocellular; Solid tumours
상세
BOXR-1030BOXR-1030Phase 2 ClinicalUnum Therapeutics Inc
Carcinoma, Hepatocellular; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Liposarcoma, Myxoid; Liver Neoplasms; Lung Neoplasms
상세
GPC3 targeting CAR-T cell therapy (Essen Biotech)Phase 2 ClinicalEssen Biotech
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms
상세
AZD-9793AZD9793; AZD-9793Phase 2 ClinicalAstrazeneca Plc
Carcinoma, Hepatocellular; Neoplasm Metastasis; Solid tumours
상세
CAR-T Cell Therapy Targeting GPC3(Pla General Hospital)Phase 2 ClinicalPla General Hospital
Carcinoma, Hepatocellular
상세
MRG-006MRG-006A; MRG-006Phase 2 ClinicalShanghai Miracogen Inc
Carcinoma, Hepatocellular; Liver Neoplasms; Neoplasms; Solid tumours
상세
C-CAR031C-CAR031; AZD-7003; TC-CAR-031; TC-CAR031; C-CAR-031Phase 2 ClinicalAstrazeneca Plc
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung
상세
NY-303NY-303Phase 2 ClinicalNAYA Biosciences Inc
Carcinoma, Hepatocellular; Solid tumours
상세
AZD-5851AZD-5851; AZD5851Phase 2 ClinicalAstrazeneca Plc
Carcinoma, Hepatocellular
상세
NWRD-06NWRD-06; NWRD06Phase 2 ClinicalNewish Technology (Beijing) Co Ltd
Carcinoma, Hepatocellular
상세
GKL-006GKL-006; GKL006Phase 2 ClinicalBeijing Gene Key Life Technology Co Ltd
Carcinoma, Hepatocellular; Liver Neoplasms; Pancreatic Neoplasms; Psoriasis
상세
CMD-011CMD-011Phase 2 ClinicalZhejiang Shimai Pharmaceutical Co Ltd
Carcinoma, Hepatocellular; Liver Neoplasms
상세
CAR-GPC3 T-cell (Drum Tower Hospital)Phase 2 ClinicalNanjing Drum Tower Hospital
Carcinoma, Hepatocellular
상세
GPC3 CAR-T therapy (Hrain Biotechnology)Phase 2 ClinicalHrain Biotechnology Co Ltd
Carcinoma, Hepatocellular
상세
CM-350CM-350Phase 2 ClinicalKeymed Biosciences Co Ltd
Solid tumours
상세
GPC3-CAR-T cell therapy(Origincell Medical Technology)Ori-CAR-001; Ori-C101(OriCell)Phase 2 ClinicalOriCell Therapeutics Co Ltd
Carcinoma, Hepatocellular
상세
ECT-204ECT-204; JWATM-204; ECT204Phase 2 ClinicalEureka Therapeutics Inc, Jw Therapeutics (Shanghai) Co Ltd
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Liver Neoplasms
상세
CodrituzumabGC-33; RO-5137382; RG-7686; ERY-974; PPMX-T001Phase 1 ClinicalPerseus Proteomics Inc
Carcinoma, Hepatocellular; Solid tumours
상세
GPC3-T2 CAR-T cell therapy (The Second Affiliated Hospital of Guangzhou Medical University)Phase 1 ClinicalSecond Affiliated Hospital Of Guangzhou Medical University
Carcinoma, Hepatocellular; Carcinoma, Squamous Cell
상세
GLYCAR T cell therapy (Baylor College of Medicine)GLYCARPhase 1 ClinicalBaylor College Of Medicine
Carcinoma, Hepatocellular; Endodermal Sinus Tumor; Hepatoblastoma; Liposarcoma; Liver Neoplasms; Rhabdoid Tumor; Rhabdomyosarcoma; Wilms Tumor
상세
Anti-GPC3 CAR T-cell therapy (Carbiogene Therapeutics)CBG166; CBG-166Phase 1 ClinicalCarbiogene Therapeutics Co Ltd, Nanjing University
Carcinoma, Hepatocellular
상세
GPC3-CAR-T cell therapyCSG-GPC-3; CAR-GPC3 T-cell; GPC3-CAR/CSG-GPC3; anti-GPC-3 CAR T; KJgpc3-001; CT-011Phase 1 ClinicalCarsgen Biomedicine (Shanghai) Co Ltd
Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Solid tumours
상세
Anti-GPC3 chimeric antigen receptor T cell therapy (Hunan Zhaotai Yongren Biotech/Guangdong Zhaotai Invivo Biomedicine)Phase 1 ClinicalGuangdong Zhaotai Invivo Biomedicine Co Ltd, Hunan Zhaotai Yongren Biotech Co Ltd
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung
상세
anti-GPC3 CAR T-cell therapy (National Institutes of Health Clinical Center)Phase 1 ClinicalNational Institutes Of Health Clinical Center (Cc)
Carcinoma, Hepatocellular
상세
anti-GPC3 CAR T-cell therapy (Nanjing Drum Tower Hospital)Phase 1 ClinicalNanjing Drum Tower Hospital
Carcinoma, Hepatocellular
상세
GPC3-T2-CAR-TGPC3-T2-CAR-TPhase 1 ClinicalSecond Affiliated Hospital Of Guangzhou Medical University
Carcinoma, Hepatocellular
상세
EU-307EU307Phase 1 ClinicalEutilex
Carcinoma, Hepatocellular; Liver Neoplasms
상세
Ori-CAR-002Ori-CAR-002; GPC3-CAR-Ori2Phase 1 ClinicalOriCell Therapeutics Co Ltd
Multiple Myeloma
상세
SENTI-301SENTI-301; SENTI-301A; SN301APhase 1 ClinicalSenti Biosciences Inc
Carcinoma, Hepatocellular; Liver Neoplasms
상세
Super CAR-T cell therapy (FineImmune Biotechnology)Phase 1 ClinicalGuangzhou Fineimmune Biotechnology
Carcinoma, Hepatocellular
상세
TC-G203TC-G203; TCG203Phase 1 ClinicalBeijing GoBroad Hospital
Carcinoma, Hepatocellular; Solid tumours
상세
I-124 CodrituzumabPhase 1 ClinicalChugai Pharmaceutical Co Ltd, Hoffmann-La Roche Inc, Memorial Sloan Kettering Cancer Center
Carcinoma, Hepatocellular
상세
225Ac-RYZ-811225Ac-RYZ-811Phase 1 ClinicalPeptiDream Inc
Carcinoma, Hepatocellular
상세
OriC-902OriC-902; OriC902Phase 1 ClinicalOriCell Therapeutics Co Ltd
Carcinoma, Hepatocellular
상세
BAY-3547926BAY3547926; BAY-3547926Phase 1 ClinicalBayer AG
Carcinoma, Hepatocellular
상세
MT-303(Myeloid)MT-303(Myeloid)Phase 1 ClinicalMyeloid Therapeutics Inc
Carcinoma, Hepatocellular
상세
68Ga-aGPC3-scFv/Fab68Ga-aGPC3-scFv/FabPhase 1 ClinicalWuhan Union Hospital
Liver Neoplasms
상세
BGB-B2033BGB-B-2033; BGB-B2033Phase 1 ClinicalBeigene Guangzhou Biologics Manufacturing Co Ltd
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Neoplasms; Solid tumours; Stomach Neoplasms
상세
BC-2027BC2027; BC-2027Phase 1 ClinicalWuxi BioCity
Liver Neoplasms; Solid tumours
상세
JMT-106JMT106; JMT-106Phase 1 ClinicalCSPC Pharmaceutical Group Ltd
Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Solid tumours
상세
AST-201 (Aptamer Sciences)AST-201(Aptamer Sciences)Phase 1 ClinicalAptamer Sciences Inc
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Liver Neoplasms; Neoplasms; Solid tumours
상세
GPC3/Mesothelin-CAR-γδT Cells therapy(Second Affiliated Hospital Of Guangzhou Medical University)Phase 1 ClinicalSecond Affiliated Hospital Of Guangzhou Medical University
Liver Neoplasms; Lung Neoplasms; Mesothelioma; Pancreatic Neoplasms; Solid tumours
상세
ZW-251ZW-251Phase 1 ClinicalZymeworks Inc
Carcinoma, Hepatocellular
상세
68Ga-RYZ-811RYZ811(68Ga); 68Ga-Ga-RYZ-GPC3; 68Ga-GPC3; 68Ga-RYZ-811; RYZ-811Phase 1 ClinicalPeptiDream Inc, RayzeBio Inc
Carcinoma, Hepatocellular
상세
GPC3-targeted CAR-T (Peking University)Phase 1 ClinicalPeking University
Carcinoma, Hepatocellular
상세
CAR (hYP7)-T cells (National Cancer Institute)Phase 1 ClinicalNational Cancer Institute
Carcinoma, Hepatocellular
상세
QLS-31903QLS31903; QLS-31903Phase 1 ClinicalQilu Pharmaceutical Co Ltd
Solid tumours
상세
SAR-444200SAR-444200Phase 1 ClinicalSanofi
Neoplasms; Solid tumours
상세
IM-83 CAR-T cell therapyIM-83; IM83Phase 1 ClinicalImunopharm Technology Co Ltd
Carcinoma, Hepatocellular; Liver Neoplasms; Neoplasms; Osteosarcoma
상세
JWATM-214JWATM-214; JWATM214Phase 1 ClinicalSuzhou Yaomingjunuo Biotechnology Co Ltd
Carcinoma, Hepatocellular; Liver Neoplasms
상세
TH-012(Bangentai Biomedical)TH-012Phase 1 ClinicalShandong Bangentai Biomedical Tech Group Co Ltd
Pancreatic Neoplasms; Stomach Neoplasms
상세
B010-AB010-APhase 1 ClinicalShanghai Pharmaceuticals Holding Co Ltd
Carcinoma, Hepatocellular
상세
CT-0180CT-0180Phase 1 ClinicalCARsgen Therapeutics Holdings Ltd
Carcinoma, Hepatocellular
상세
HRAIN-011HRAIN-011ClinicalHrain Biotechnology Co Ltd
Carcinoma, Hepatocellular
상세
[68Ga]Ga-NOTA-G5ClinicalRenji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine
Digestive System Neoplasms
상세
[18F]F-RESCA-G5ClinicalRenji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine
Digestive System Neoplasms
상세
Anti-GPC3-IRDye800CWClinicalChinese Academy Of Sciences
상세
Customer Reviews
  • 1***62019-10-11
    GPC3 is also currently a popular target for solid tumors. I bought this product to detect the positive rate of CAR-T cells. The result was the same with the one performed using our own purified expressed protein (added hFc tag, which requires fluorescent labeled secondary antibodies). But no need to dye for secondary antibodies, so this one from ACRO was more convenient.